Brief: Cyclo Therapeutics Provides Business Update And Reports First Quarter 2023 Financial Results
May 15 (Reuters) - Cyclo Therapeutics Inc CYTH.O :
* CYCLO THERAPEUTICS PROVIDES BUSINESS UPDATE AND REPORTS
FIRST
QUARTER 2023 FINANCIAL RESULTS
* CYCLO THERAPEUTICS - ENDED QUARTER ON A PRO FORMA BASIS
WITH
ABOUT $3.0 MILLION OF CASH
* CYCLO THERAPEUTICS - EXPECTS RESEARCH AND DEVELOPMENT
COSTS TO
INCREASE IN 2023 AS CO TO SEEK REGULATORY APPROVAL FOR USE OF
TRAPPSOL IN TREATMENT OF NPC & ALZHEIMER'S
Source text for Eikon: ID:nBwbshgYGa
Further company coverage: CYTH.O
((Reuters.Brief@thomsonreuters.com;))
Recent news on Cyclo Therapeutics
See all newsBrief: Rafael Holdings Completes Merger With Cyclo Therapeutics Following Shareholder Approvals
Cyclo Therapeutics Inc expected to post a loss of 16 cents a share - Earnings Preview
Brief: Cyclo Therapeutics Inc Issues $2.5 Million Convertible Promissory Note To Rafael Holdings
U.S. STOCKS ON THE MOVE-McDonald, Uber, SolarWinds
Cyclo Therapeutics jumps on prelim late-stage data of genetic disorder drug